Dr. Quinnan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
14508 Manor Park Dr
Rockville, MD 20853Phone+1 301-460-6625
Education & Training
Boston University Medical CenterResidency, Internal Medicine, 1973 - 1977
Saint Louis University School of MedicineClass of 1973
Certifications & Licensure
MD State Medical License 1979 - 2021
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1985
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 17 citationsConducting clinical trials in sub-Saharan Africa: challenges and lessons learned from the Malawi Cryptosporidium study.Neema Toto, Elaine Douglas, Markus Gmeiner, Lynn K. Barrett, Robert Lindblad
Trials. 2020-07-25 - 11 citationsEvaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial.Patrick Nachipo, David Hermann, Gerald Quinnan, Melita A. Gordon, Wesley C. Van Voorhis
Trials. 2018-08-23 - 1 citationsHumoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort.Elizabeth Fink, Katherine Fuller, Brian K. Agan, Edward A. Berger, Andrew C. S. Saphire
AIDS Research and Human Retroviruses. 2016-12-01
Grant Support
- High Potency HIV-1 Broadly Cross-Reactive NeutralizationNational Institute Of Allergy And Infectious Diseases2008–2012
- Highly Effective Neutralizing Antibodies Against SHIVNational Institute Of Allergy And Infectious Diseases2005–2009
- Neutralization Resistance Of HIV-1National Institute Of Allergy And Infectious Diseases2001–2005
- Broadly Effective Neutralization And CTL Against HIV 1National Institute Of Allergy And Infectious Diseases2001–2003
- Broad Neutralizing Response To Hivenv/Vee RepliconsNational Institute Of Allergy And Infectious Diseases2001–2002
- Neutralization Resistance Of HIV-1National Institute Of Allergy And Infectious Diseases1999
- Broad Neutralizing Response To Hiv/Vee RepliconsNational Institute Of Allergy And Infectious Diseases1998–1999
- Neutralization Resistance Of HIV1National Institute Of Allergy And Infectious Diseases1998
- Neutralization Resistance Of HIV 1National Institute Of Allergy And Infectious Diseases1995–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
